EMG
ANGO icon

Ellington Management Group’s AngioDynamics ANGO Stock Holding History

Ellington Management Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,400
Closed -$108K – 62
2020
Q1 		$108K Buy
+10,400
New +$131K 0.03% 492
2019
Q4 		– Sell
-16,800
Closed -$309K – 510
2019
Q3 		$309K Buy
+16,800
New +$329K 0.06% 357
2017
Q2 		– Sell
-12,100
Closed -$210K – 629
2017
Q1 		$210K Buy
+12,100
New +$202K 0.01% 575

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Ellington Management Group's ANGO Position: Q2 2020 in Review

Ellington Management Group sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 10,400 shares — an estimated $108K sold.

Ellington Management Group first reported a position in ANGO in Q1 2017 and held it in 3 quarters. The position peaked at $309K in Q3 2019. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

  • Ellington Management Group reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 10,400 AngioDynamics shares in Q2 2020, an estimated $108K.
  • Ellington Management Group first reported a position in AngioDynamics in Q1 2017 and held it in 3 quarters.
  • Ellington Management Group's AngioDynamics position peaked at $309K in Q3 2019.
  • 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.